Tags

Type your tag names separated by a space and hit enter

Shear distribution and variability in the USP Apparatus 2 under turbulent conditions.
Int J Pharm. 2004 Jul 26; 279(1-2):9-17.IJ

Abstract

Computational analysis is used to examine the hydrodynamic environment within the USP Apparatus II at common operating conditions. Experimental validation of the computational model shows that the simulations of fluid motion match the dispersion of dye observed in experiments. The computations are then used to obtain data that cannot be easily measured with experiments, specifically the distribution of shear forces within the media and along the wall. Results show that the shear environment is highly non-uniform. Increasing the paddle speed from 50 to 100 rpm does not improve shear homogeneity within the apparatus. Experiments show that this uneven distribution of hydrodynamic forces is a direct cause of dissolution testing variability. This variability is large enough to cause for type II dissolution test failures, i.e., failures are a result of a vulnerability of the testing method rather than a problem with a dosage form. Future development of new dissolution tests should include evaluations of the hydrodynamic environments to eliminate this potential source of failure that is unrelated to product quality.

Authors+Show Affiliations

Department of Chemical & Biochemical Engineering, Rutgers University, 98 Brett Road, Piscataway, NJ 08854, USA.No affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

15234789

Citation

Kukura, J, et al. "Shear Distribution and Variability in the USP Apparatus 2 Under Turbulent Conditions." International Journal of Pharmaceutics, vol. 279, no. 1-2, 2004, pp. 9-17.
Kukura J, Baxter JL, Muzzio FJ. Shear distribution and variability in the USP Apparatus 2 under turbulent conditions. Int J Pharm. 2004;279(1-2):9-17.
Kukura, J., Baxter, J. L., & Muzzio, F. J. (2004). Shear distribution and variability in the USP Apparatus 2 under turbulent conditions. International Journal of Pharmaceutics, 279(1-2), 9-17.
Kukura J, Baxter JL, Muzzio FJ. Shear Distribution and Variability in the USP Apparatus 2 Under Turbulent Conditions. Int J Pharm. 2004 Jul 26;279(1-2):9-17. PubMed PMID: 15234789.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Shear distribution and variability in the USP Apparatus 2 under turbulent conditions. AU - Kukura,J, AU - Baxter,J L, AU - Muzzio,F J, PY - 2003/10/21/received PY - 2004/03/19/revised PY - 2004/03/19/accepted PY - 2004/7/6/pubmed PY - 2004/11/13/medline PY - 2004/7/6/entrez SP - 9 EP - 17 JF - International journal of pharmaceutics JO - Int J Pharm VL - 279 IS - 1-2 N2 - Computational analysis is used to examine the hydrodynamic environment within the USP Apparatus II at common operating conditions. Experimental validation of the computational model shows that the simulations of fluid motion match the dispersion of dye observed in experiments. The computations are then used to obtain data that cannot be easily measured with experiments, specifically the distribution of shear forces within the media and along the wall. Results show that the shear environment is highly non-uniform. Increasing the paddle speed from 50 to 100 rpm does not improve shear homogeneity within the apparatus. Experiments show that this uneven distribution of hydrodynamic forces is a direct cause of dissolution testing variability. This variability is large enough to cause for type II dissolution test failures, i.e., failures are a result of a vulnerability of the testing method rather than a problem with a dosage form. Future development of new dissolution tests should include evaluations of the hydrodynamic environments to eliminate this potential source of failure that is unrelated to product quality. SN - 0378-5173 UR - https://www.unboundmedicine.com/medline/citation/15234789/Shear_distribution_and_variability_in_the_USP_Apparatus_2_under_turbulent_conditions_ DB - PRIME DP - Unbound Medicine ER -